MICRUS ENDOVASCULAR CORP (MEND) is a publicly traded company in the Unknown sector. Across all available filings, 16 corporate insiders have executed 767 transactions totaling $37.6M, demonstrating a bearish sentiment with -$29.5M in net insider flow. The most recent transaction on Sep 27, 2010 involved a transaction of 9,182 shares valued at $0.
No significant insider buying has been recorded for MEND in the recent period.
No significant insider selling has been recorded for MEND in the recent period.
Based on recent SEC filings, insider sentiment for MEND is bearish with an Insider Alignment Score of 11/100 and a net flow of -$29.5M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at MICRUS ENDOVASCULAR CORP (MEND) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 16 insiders are actively trading MEND stock, having executed 767 transactions in the past 90 days. The most active insider is Bioventures Cayman Ltd Hbm (Executive), who has made 409 transactions totaling $13.7M.
Get notified when executives and directors at MEND file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Sep 27, 2010 | M. Bruguera Carolyn | Executive | Disposition | 9,182 | $N/A | $0 | |
| Sep 27, 2010 | C. Colloton Robert | Executive | Disposition | 25 | $N/A | $0 | |
| Sep 27, 2010 | Holubow Fred | Executive | Disposition | 18,167 | $N/A | $0 | |
| Sep 27, 2010 | Nelson Hopkins Leo | Executive | Disposition | 1,500 | $N/A | $0 | |
| Sep 27, 2010 | T. Kilcoyne John | Executive | Disposition | 8,056 | $N/A | $0 | |
| Sep 27, 2010 | F. Ruppel Edward Jr | Executive | Disposition | 3,744 | $N/A | $0 | |
| Sep 27, 2010 | Snyder Richard | Executive | Disposition | 4,802 | $N/A | $0 | |
| Sep 27, 2010 | Sangster Gordon | Executive | Disposition | 5,555 | $N/A | $0 | |
| Sep 27, 2010 | A. Stern Robert | Executive | Disposition | 10,924 | $N/A | $0 | |
| Sep 27, 2010 | A. Stern Robert | Executive | Disposition | 111 | $N/A | $0 | |
| Sep 27, 2010 | H. Thiel Jeffrey | Executive | Disposition | 9,202 | $N/A | $0 | |
| May 17, 2010 | M. Bruguera Carolyn | Executive | Sale | 7 | $17.89 | $125 | |
| Mar 3, 2010 | Cayman Ltd Hbm Bioventures | Executive | Sale | 21,200 | $20.98 | $444.8K | |
| Mar 2, 2010 | Cayman Ltd Hbm Bioventures | Executive | Sale | 46,196 | $21.15 | $977.0K | Large |
| Feb 28, 2010 | C. Colloton Robert | Executive | Award | 25 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 430 | $33.6M | 81.6% |
Purchase(P) | 269 | $4.0M | 9.8% |
Award(A) | 7 | $2.5M | 6.1% |
Exercise(M) | 37 | $959.8K | 2.3% |
Payment(F) | 3 | $56.8K | 0.1% |
Disposition(D) | 11 | $0 | 0.0% |
Other(J) | 2 | $0 | 0.0% |
Gift(G) | 4 | $0 | 0.0% |
Conversion(C) | 4 | $0 | 0.0% |
Insider selling pressure at MICRUS ENDOVASCULAR CORP has increased, with 16 insiders executing 767 transactions across all time. Total sales of $33.6M significantly outpace purchases of $4.0M, resulting in a net outflow of $29.5M. This selling activity appears largely discretionary, which may warrant closer attention from investors.